Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers​", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Kristiansen CH, Thomas O, Nyquist AB, Sanderud A, Boavida J, Geitung JT, Tran TT, Lauritzen PM(2025) A randomised controlled trial comparing three clinical administration strategies in spectral detector CT pulmonary angiography with low contrast medium dose Eur Radiol(in press) DOI 10.1007/s00330-025-11420-8, PubMed 39969554
Fullerton JM, Tesfaye M(2025) Global diversity in bipolar disorder: the role of cultural and social differences with a view to genomics Biol Psychiatry(in press) DOI 10.1016/j.biopsych.2025.02.008, PubMed 39956255
Parker N, Ching CRK(2025) Mapping structural neuroimaging trajectories in bipolar disorder: neurobiological and clinical implications Biol Psychiatry(in press) DOI 10.1016/j.biopsych.2025.02.009, PubMed 39956253